期刊文献+

复方口服避孕药治疗女性痤疮的研究进展 被引量:2

下载PDF
导出
摘要 随着对痤疮发病机制认识的不断加深,其治疗出现了许多新的思路及方法,如复方口服避孕药(combined oral contraceptives,COCs)的应用。目前已有较多研究证实其对痤疮有肯定的疗效,了解其作用机制、疗效及风险对于皮肤科医生来说是十分必要的。本文拟对复方口服避孕药在女性痤疮治疗中的研究进展做一综述。
出处 《皮肤性病诊疗学杂志》 2015年第2期152-154,共3页 Journal of Diagnosis and Therapy on Dermato-venereology
  • 相关文献

参考文献17

  • 1Das S,Reynolds RV.Recent Advances in Acne Pathogenesis:Implications for Therapy[J].Am J Clin Dermatol,2014,15(6):479-488.
  • 2骆伟雄.痤疮患者血清性激素水平分析[J].皮肤性病诊疗学杂志,2010,17(5):357-358. 被引量:16
  • 3Junkins-Hopkins JM.Hormone therapy for acne[J].J Am Acad Dermatol,2010,62(3):486-488.
  • 4Kurokawa I,William Danby F,Ju Q,et al.New developments in our understanding of acne pathogenesis and treatment[J].Exp Dermatol,2009,18(10):821-832.
  • 5Schindler AE,Campagnoli C,Druckmann R,et al.Classification and pharmacology of progestins[J].Maturitas,2003,(Suppl 1):s7-s16.
  • 6Maloney JM,Dietze P Jr,Watson D,et al.Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen:a randomized controlled trial[J].Obstet Gyneclo,2008,112(4):773-781.
  • 7Kranzlin HT,Nap MA.The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acne[J].Eur J Contracept Reprod Health Care,2006,11(1):6-13.
  • 8van Vloten WA,van Haselen CW,van Zuuren EJ,et al.The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea[J].Cutis,2002,69(4 Suppl):2-15.
  • 9Arowojolu AO,Gallo MF,Lopez LM,et al.Combined oral contraceptive pills for treatment of acne[J].Cochrane Database Syst Rev,2012,7:CD004425.
  • 10Thorneycroft l H,Gollnick H,Schellschmidt I.Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment[J].Cutis,2004,74(2):123-130.

二级参考文献4

共引文献19

同被引文献32

  • 1DIAMANTI-KANDARAKIS E, CHRISTAKOU CD, KANDARAKI E, et al. Metformin : all old medication of new fashion: evolving newmolecular mechanisms and clinical implications in polyeystie ovary syndrome [J]. Eur J Endocrinol, 2010,162(2) : 193-212.
  • 2DOMECG JP, PRUTSKY G, MULLAN R J, et al. Adverse effects of the common treatments for polycystic ovary syndrome : a systematic review and meta-analysis [J]. J Clin Endocrinol Metab, 2013,98 (12) : 4646 - 4654.
  • 3CONWAY G, DEWAILLY D, DIAMANTI-KANDARAKIS E, et al. The polycystic ovary syndrome: a position statement from the European society of endocrinology [Jl. Eur J Endocrinol, 2014, 171 (4) : 1-29.
  • 4SANDSET PM. Mechanisms of hormonal therapy related thrombosis [ J ]. Thromb Res, 2013,131 ( 1 ) : 4-7.
  • 5MANZOLI L, DE VITO C, MARZUILLO C, et al. Oral contraceptives and venous thromboembolism: a systematic review and Meta-analysis [J]. Drug Saf, 2012,35(3) : 191-205.
  • 6STOCCO B, FUMAGALLI HF, FRANCESCHINI SA, et al. Comparative study of the effects of combined oral contraceptives in hemostatic variables:an Observational preliminary study [J ]. Medicine, 2015,94 (4) : e385.
  • 7TOULIS KA, GOULIS DG, MINTZIORI G, et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome [J]. Hum Reprod Update, 2011,17(6):741- 760.
  • 8CARMINA E. Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome [ J ]. Endocrinol Invest, 2013,36(5 ) : 358-363.
  • 9GLINTBORG D, SIDELMANN JJ, ALTINOK ML, et al. Increased Thrombin generation in women with polycystie ovary syndrome: A pilot study on the effect of mefforminand oral contraceptives [J ]. Metabolism, 2015,64(10) : 1272-1278.
  • 10BIRD ST, HARTZEMA AG, BROPHY JM, et al. Risk of venous thromboembolism in women with polycystie ovary syndrome: a population-based matched cohort analysis[J].CMAJ, 2013,185(2) :El15-E120.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部